VAERS Reports UJ448AB

VAERS 2589028

PROTEIN SCIENCES CORPORATION · INFLUENZA (SEASONAL) (FLUBLOK QUADRIVALENT) · Charge UJ448AB

mild

Staat: SC
Alter: 75,0
Geschlecht: F
Eingang: 28.02.2023
Impfdatum: 08.10.2020
Beginn: 27.10.2020
Tage bis Beginn: 19,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Malaise Rash

Symptomtext

patient states she has not been well and has had a rash for over 2 years

Weitere VAERSDATA-Felder

Praegender Schweregrund: Malaise
Hospital-Tage: -
Labordaten: unknown
Aktuelle Erkrankungen: unknown
Vorgeschichte: unknown
Andere Medikamente: unknown
Allergien: Codeine, Penicillins, Sulfa
Vorherige Impfungen: -

VAERS 1080670

PROTEIN SCIENCES CORPORATION · INFLUENZA (SEASONAL) (FLUBLOK QUADRIVALENT) · Charge UJ448AB

gering

Staat: KY
Alter: 28,0
Geschlecht: F
Eingang: 08.03.2021
Impfdatum: -
Beginn: -
Tage bis Beginn: -
Dosis: UNK
Route/Site: OT / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Exposure during pregnancy Influenza

Symptomtext

flu; administered 2 vaccines to a pregnant patient, Flublok and Adacel with no reported adverse event; Initial information was received on 17-Feb-2021 regarding an unsolicited valid non-serious case from a pharmacist (Inquiry Number: 00479816). This case involves a 28-year-old female patient who experienced flu and administered 2 vaccines to a pregnant patient, flublok and adacel, while she received INFLUENZA QUADRIVALENT RECOMBINANT VACCINE [FLUBLOK QIV] (Batch number: UJ448AB, Expiry date: 22-Mar-2021). The event occurred at unknown gestation period. Data regarding this pregnancy were received prospectively for example before pregnancy outcome was known. The date of last menstrual period was not reported. The estimated due date is 05-Apr-2021. Gestation period at onset was unknown. The patient's medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included DIPHTHERIA VACCINE TOXOID, PERTUSSIS VACCINE ACELLULAR 5-COMPONENT, TETANUS VACCINE TOXOID (ADACEL). It was a case of vaccine exposure during pregnancy as patient was pregnant when she received vaccine. Relevant prenatal testing after exposure was not reported. At the time of reporting, the patient experienced flu and the event outcome is unknown.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Exposure during pregnancy
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: ADACEL
Allergien: -
Vorherige Impfungen: -

VAERS 933930

PROTEIN SCIENCES CORPORATION · INFLUENZA (SEASONAL) (FLUBLOK QUADRIVALENT) · Charge UJ448AB

gering

Staat: AL
Alter: 26,0
Geschlecht: F
Eingang: 11.01.2021
Impfdatum: 12.10.2020
Beginn: 28.10.2020
Tage bis Beginn: 16,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Exposure during pregnancy Neuropathy peripheral

Symptomtext

36 weeks pregnant as of 1/12/2021 left arm neuropathy

Weitere VAERSDATA-Felder

Praegender Schweregrund: Exposure during pregnancy
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -